Diageo Shares Plunge as Spirits Giant Reports Revenue Miss, Cuts Guidance

BenzingaBenzinga
|||1 min read
Key Takeaway

Diageo misses revenue targets at $10.5B, cites weak US and China demand. Shares plunge 13.6% after company cuts full-year guidance citing consumer spending constraints.

Diageo Shares Plunge as Spirits Giant Reports Revenue Miss, Cuts Guidance

Diageo Plc, the London-listed beverages company behind iconic brands including Smirnoff vodka and Guinness stout, reported first-half fiscal 2026 results that fell short of analyst expectations, prompting a significant market correction. The company posted net sales of $10.5 billion for the period, underperforming consensus estimates of $11.11 billion and reflecting broader headwinds in key markets including the United States and China.

The earnings shortfall reflects mounting pressure from several operational challenges. Soft demand in the American spirits market, traditionally a core revenue driver, combined with weakness in Chinese white spirits sales to dampen overall performance. Additionally, the company cited consumer constraints on discretionary spending as a contributing factor to the underperformance across its portfolio.

In response to the weaker trading environment, Diageo revised its full-year fiscal 2026 guidance downward. Management now expects organic net sales to decline between 2% and 3%, while organic operating profit growth is projected to range from flat to low single-digit growth. The announcement triggered a sharp market reaction, with Diageo's share price declining 13.60% on the day of disclosure.

Source: Benzinga

Back to newsPublished Feb 25

Related Coverage

GlobeNewswire Inc.

MVST Stock Plunges 34% After Disastrous Earnings; Law Firm Launches Fraud Investigation

Microvast ($MVST) plunged 34% after reporting $96.5M revenue (29% below consensus) and 1% gross margins, triggering securities fraud investigation by Pomerantz LLP.

MVSTMVSTW
Benzinga

KB Home Shares Slide on 23% Revenue Decline, Margin Compression in Q1

KB Home stock fell 4.8% after Q1 earnings missed expectations, with revenue down 23% year-over-year and operating margins compressed to 3.1%.

KBH
Investing.com

O'Reilly Automotive Hits 52-Week Low: Temporary Setback or Genuine Opportunity?

$ORLY hits 52-week low on narrow earnings miss despite 7.8% revenue growth and double-digit DIFM expansion. Analysts see 27% upside opportunity.

ORLY
Benzinga

ALIT Shareholders Face Class Action Deadline as Securities Fraud Lawsuit Claims Material Misstatements

$ALIT shareholders have until May 15, 2026 to join securities fraud lawsuit over alleged misstatements. Stock fell 18.3% and 38.2% after guidance misses in August 2025 and February 2026.

ALIT
The Motley Fool

Lenz Therapeutics Stock Crashes 11.2% on Missed Earnings and Weak VIZZ Launch

Lenz Therapeutics stock plummeted 11.2% after Q4 earnings miss, larger-than-expected losses, and disappointing VIZZ prescription uptake despite strong pipeline projections.

LENZ
The Motley Fool

Major Shareholder Trims $7.8M Harrow Stake, Signals Profit-Taking Over Retreat

Opaleye Management sold $7.8M in $HARR shares while retaining 10% stake, suggesting tactical rebalancing rather than loss of confidence in ophthalmic pharma company.

HROW